Canaccord Genuity Maintains Hold on Smith & Nephew, Lowers Price Target to $30
Smith & Nephew Sees FY2026 Sales $6.534B vs $6.557B Est
Smith & Nephew plc (SNN) Q1 2026 Sales/Trading Call Transcript
Smith & Nephew plc (SNN) Q1 2026 Sales/ Trading Statement Call - Slideshow
Smith+Nephew To Showcase ALLEVYNCOMPLETE CARE Dressing And RENASYS EDGE tNPWT, To Simplify Wound Management And Ease Clinical Burden At EWMA 2026
Smith & Nephew (NYSE:SNN) Qualifies as a Quality Investment Through the Caviar Cruise Screen
Smith+Nephew Reported Additional Data From Clinical Superiority Of Its CARTIHEAL AGILI-C Cartilage Repair Implant; Results Demonstrate Higher Overall Knee Injury And Osteoarthritis Outcome Scores
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading
Smith+Nephew’s REGENETEN◊ Bioinductive Implant shows post-operative recovery times halved, and high healing rates for partial-thickness rotator cuff tears1,*
Smith+Nephew Announces New RCT Data Confirming Outcome Improvements For Patients With Partial-Thickness Rotator Cuff Tears Treated With REGENETEN Bioinductive Implant In Isolation
How The Story Is Shifting For S.N. Nuclearelectrica (BVB:SNN) With A Steady RON 49 Target
Smith & Nephew PLC (NYSE:SNN) Passes the Caviar Cruise Screen for Quality Investing
How The S.N. Nuclearelectrica (BVB:SNN) Story Is Shifting As Fair Value Stays Put
How the FTSE grew comfortable with bumper pay for bosses
Smith+Nephew launches next-generation ALLEVYN™ COMPLETE CARE Foam Dressing - designed for high performance in wound management and pressure injury prevention
Smith & Nephews Announces Launch Of New ALLEVYN Foam Dressings For Wound Management And Pressure Injury Prevention
European Equities Traded in the US as American Depositary Receipts Slide in Thursday Trading
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
Smith & Nephew PLC (SNN) Full Year 2025 Earnings Call Highlights: Strong Revenue Growth and ...
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.